Skip to Content
Symphonies
BioTech v2
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Tactical biotech strategy: if biotech is in an uptrend, hold the two strongest biotech names; otherwise rotate into the most oversold defensive ETFs (bonds and defensive sectors). Equal‑weighted, rebalanced monthly.
NutHow it works
Each month it checks if biotech is rising using IBB (a biotech ETF): is the 50‑day average price above the 200‑day? If yes, buy the 2 biotech stocks with the strongest recent momentum by 14‑day RSI (a 0–100 gauge of recent gains). If not, buy 2 defensive ETFs (bonds, staples, utilities, health care) with the lowest 10‑day RSI (most beaten‑down). Equal‑weight; cash holds any leftover.
CheckmarkValue prop
Out-of-sample stats suggest this strategy can outperform the S&P 500: it rides biotech leaders in uptrends and shifts to beaten-down defensive ETFs in downturns, with monthly rebalancing that trims risk and preserves capital.
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
0.840.770.050.21
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
63.48%12.96%-2.85%-2.42%0.78
BioTech v2
2,035.82%113.68%-2.59%-21.74%1.47
Initial Investment
$10,000.00
Final Value
$213,581.51
Regulatory Fees
$83.34
Total Slippage
$412.19
Invest in this strategy
OOS Start Date
Feb 27, 2026
Trading Setting
Monthly
Type
Stocks
Category
Biotech, trend filter (50/200 ma), momentum (rsi), defensive rotation, tactical, monthly rebalance
Tickers in this symphonyThis symphony trades 20 assets in total
Ticker
Type
ACLX
Arcellx, Inc. Common Stock
Stocks
AVXL
Anavex Life Sciences
Stocks
BSV
Vanguard Short-Term Bond ETF
Stocks
IBB
iShares Biotechnology ETF
Stocks
LQD
iShares iBoxx $ Investment Grade Corporate Bond ETF
Stocks
NRSN
NeuroSense Therapeutics Ltd. Ordinary Shares
Stocks
PCVX
Vaxcyte, Inc. Common Stock
Stocks
PLUR
Pluri Inc. Common Stock
Stocks
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
Stocks
RZLT
Rezolute, Inc. Common Stock (NV)
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"BioTech v2" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"BioTech v2" is currently allocated toPCVXandACLX. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "BioTech v2" has returned -74.76%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "BioTech v2" is 5.83%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "BioTech v2", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, and options.